NeoGenomics, Inc. (NEO) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-17 12:55:13 ET
NeoGenomics, Inc. (NEO) Q4 2025 Earnings Call February 17, 2026 8:30 AM EST
Company Participants
Kendra Sweeney - Vice President of Investor Relations & Communications
Anthony Zook - CEO & Director
Jeffrey Sherman - Chief Financial Officer
Abhishek Jain - Executive Vice President of Finance
Warren Stone - President & COO
...
Read the full article on Seeking Alpha
For further details see:
NeoGenomics, Inc. (NEO) Q4 2025 Earnings Call Transcript
NeoGenomics Inc.
NASDAQ: NEO
NEO Trading
-1.8% G/L:
$8.725 Last:
340,070 Volume:
$8.88 Open:
NEO Latest News
February 25, 2026 07:05:00 am
NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types
NEO Stock Data
$1,500,898,492
126,282,494
0.16%
88
N/A
Medical Diagnostics & Screening
Healthcare
US
Fort Myers
